Science, Computers & Technology Business Organization Civil Procedure

Read Science, Computers & Technology updates, news, alerts, and legal analysis from leading lawyers and law firms:
News & Analysis as of

Is Safe Harbor Still Safe? U.S. Companies Face Challenges Ahead on the EU Privacy Horizon

Pursuant to European Commission Decision 2000/520, United States–based companies may freely process the personal data of European Union citizens, provided that those companies adhere to the principles and frequently asked...more

Theratechnologies Inc. V. 12185 Canada Inc: Supreme Court Of Canada Raises The Bar For Obtaining Leave To Bring Secondary Market...

In Theratechnologies inc. v. 12185 Canada inc., the Supreme Court of Canada has ruled that requirements that plaintiffs demonstrate that their claims have been brought in good faith and have a reasonable chance of succeeding...more

Strategies for Pharma Companies Facing Bass-Like Challenges in IPR Proceedings

Kyle Bass is at it again. On April 20, 2015, Bass filed his sixth inter partes review (IPR) Petition against a patent covering Pharmacyclics, Inc.’s cancer drug, IMBRUVICA®. Then, on April 22, 2015, Bass filed his seventh IPR...more

First Secondary Market Class Action to Reach SCC Denied Leave

In a decision released on April 17, 2015, the Supreme Court of Canada (SCC) overturned the Québec Court of Appeal’s judgment in Theratechnologies Inc. v. 121851 Canada Inc. (See our July 2013 Blakes Bulletin: Statutory...more

Environmental Appeals Board Vacates Penalties for TSCA Section 8(e) Violations

The U.S. Environmental Appeals Board (EAB) issued an opinion this month that sheds light on section 8(e) of the Toxic Substances Control Act (TSCA); specifically, the applicability of the “continuing violations doctrine” to...more

Dechert Survey of Securities Fraud Class Actions Brought Against U.S. Life Sciences Companies

Publicly Traded Life Sciences Companies in the United States Are an Increasingly Popular Target of Securities Fraud Class Action Lawsuits - The past year was particularly noteworthy with respect to the relative number...more

Board Oversight of Cyberrisks: Directors and Officers Litigation

The duty of a board to monitor and oversee organizational risk includes cyberrisks. As cyberrisks and incidents proliferate, boards are seeking to enhance the information they receive about cyberrisks and incidents. One...more

Patent Mediation – Interview with John Delehanty, Member, Mintz Levin  [Video]

Attorney John Delehanty, Member of Mintz Levin's Intellectual Property Practice, explains the benefits of using mediation to resolve patent disputes. ...more

Storm Cloud for Insolvency Practitioners?

Cloud and Insolvency - With the increasing popularity of cloud computing, more companies are taking advantage of cheap, efficient and globally available data storage options....more

Was Lawrence DiCristina found guilty or charged in and by the state of New York for promoting gambling or anything else? (Updated...

Was Lawrence DiCristina found guilty or charged in and by the state of New York for promoting gambling or anything else? (No, he was charged by US Federal authorities) International Masters of Gaming Law (IMGL) Discussion...more

Cardroom International LLC v. Mark Scheinberg, et. al. (Ferguson, Chris)

Tentative Ruling Dismissing Case in its Entirety (LASC Judge White)

Tentative Ruling Dismissing Case in its Entirety (LASC Judge White); issued as final court ruling and findings in law and motion hearings held on June 7, 2013, at 1:30 p.m. before Hon. Elizabeth White, Judge of the Los...more

Chad Elie v. Ifrah Law PLLC

CERTIFICATE of Interested Parties filed by Defendants Alain Jeffery Ifrah, Ifrah PLLC

[Docket Text] CERTIFICATE of Interested Parties filed by Alain Jeffery Ifrah, Ifrah PLLC that identifies all parties that have an interest in the outcome of this case. . (Lund, Kenneth) (Entered: 05/21/2013)...more

In re BioClinica, Inc. Shareholder Litigation

In In re BioClinica, Inc. Shareholder Litigation, the Delaware Court of Chancery in a memorandum opinion on a motion to expedite examined the cumulative effect of deal protection devices to determine whether they should have...more

Looking Ahead: Forthcoming 2013 Securities and Corporate Governance Litigation Developments

This promises to be an eventful year in securities and corporate governance litigation. A number of looming developments have the potential to change the landscape for many years to come. This is the first of two posts – or...more

Under Agency Law, Standard Setting Organizations May Be Liable for Antitrust Violations of Their Members

As noted in this recent blog post, in TruePosition, Inc. v. LM Ericsson Telephone Co., No. 11-4574 (E.D. Pa. Oct. 4, 2012), the court held that a Standard Setting Organization (SSO) known as 3GPP may be liable for alleged...more

Lessons From In Re Rigel Pharmaceuticals

Originally published in Law360, New York (September 19, 2012, 10:56 AM ET) In In re Rigel Pharmaceuticals Inc. Securities Litigation (9th Cir. Sept. 6, 2012), the United States Court of Appeals for the Ninth Circuit...more

IP Attorneys: A Guide to Effective, Engaging Graphics for Patent Litigation

Apple’s recent victory over Samsung in their patent infringement case had to be one of the most closely watched intellectual property cases ever, and trial graphics played a decisive role in shaping juror and public opinion....more

Articles in Legal Industry Publications Continue to Qualify as Public Disclosure Under the False Claims Act

A Texas federal judge recently tossed a Federal False Claims Act (FCA) qui tam because the substance of the underlying allegations was previously disclosed in several legal industry publications, U.S. ex rel. Pharma Fraud...more

Corporate and Financial Weekly Digest - May 25, 2012

In this issue: - NYSE’s Modified Listing Standards For EGCs; Advisory Committee Proposes Change to NYSE Proxy Distribution Fees - FINRA Proposes Rule Change Regarding Front Running of Block Transactions - SEC...more

U.S. District Court for the District of Massachusetts Holds Pharmaceutical Companies Not Required to Disclose FDA Inspectional...

In an important ruling dismissing a comprehensive securities class action complaint against Genzyme Corporation, the U.S. District Court for the District of Massachusetts held last week that regulatory comments and...more

Tackling ‘Pay-For-Delay’ In California Supreme Court

Originally Published in Competition Law360 Last month, the California Supreme Court granted a petition for review to consider the legality of “pay-for-delay” agreements. Under these agreements, also referred to as...more

Deliverance Poker LLC v. Tiltware LLC and Michael Mizrachi

USDC Order Dismissing Case for lack of subject matter jurisdiction.

USDC for the WD of TX (Austin Division) Order Dismissing Case for lack of subject matter jurisdiction per Judge James R. Nowlin. ...more

T.R. Investors v. Genger

Brief of Amicus Curiae in Support of Defendant Below-Appellant Urging Reversal

This amicus brief addresses issues raised in the Court of Chancery relating to preservation and deletion of data. In the brief, amici argue that the Court misapplied technological concepts and therefore reached a conclusion...more

Supreme Court Agrees to Decide Securities Class Action with Significant Implications for the Pharmaceutical Industry and Other...

On June 14, 2010, the Supreme Court agreed to consider Matrixx Initiatives, Inc. v. Siracusano, which addresses a stockholder’s claim that a pharmaceutical company improperly failed to disclose adverse drug reactions even...more

24 Results
View per page
Page: of 1

Follow Science, Computers & Technology Updates on:

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.